Design of a peptide inhibitor that blocks the cell fusion mediated by glycoprotein 41 of human immunodeficiency virus type 1

AIDS Research and Human Retroviruses

Volumn 16, Issue 17, 2000, Pages 1797-1804

  Jin, B S ^a,b   Ryu, J R ^a   Ahn, K ^b   Yu, Yeon Gyu ^a  

^a Korea Institute of Science and Technology   (South Korea)

^b Korea University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41; PEPTIDE DERIVATIVE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; CELL FUSION; CELL MEMBRANE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; VIRUS CELL INTERACTION; VIRUS ENVELOPE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; BIOSENSING TECHNIQUES; CELL LINE; CIRCULAR DICHROISM; DRUG DESIGN; HIV ENVELOPE PROTEIN GP41; HIV-1; HUMANS; MEMBRANE FUSION; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN ENGINEERING; PROTEIN STRUCTURE, SECONDARY;

EID: 0034693932     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/08892220050195757     Document Type: Article

References (36)

1. The biochemistry of AIDS
2. Retroviral envelope glycoproteins contain a 'leucine zipper'-like repeat
3. A general model for the transmembrane proteins of HIV and other retroviruses
4. A peptide from the heptad repeat of human immunodeficiency virus gp41 shows both membrane binding and coiled-coil formation
5. Human immunodeficiency virus type I envelope glycoprotein oligomerization requires the gp41 amphipathic α-helical/leucine zipper-like sequence
6. Biophysical characterization of recombinant proteins expressing the leucine zipper-like domain of the human immunodeficiency virus type I transmembrane protein gp41
7. Propensity for a leucine zipper-like domain of human immunodeficiency virus type 1 gp41 to form oligomers correlates with a role in virus-induced fusion rather than assembly of the glycoprotein complex
8. Inhibition of HIV-1 infection by a fusion domain binding peptide from the HIV-1 envelope glycoprotein GP41
9. Peptides corresponding to a predictive α-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection
10. A trimeric structural domain of the HIV-1 transmembrane glycoprotein
11. HIV-1 membrane fusion mechanism: Structural studies of the interactions between biologically-active peptides from gp41
12. Core structure of gp41 from the HIV envelope glycoprotein
13. Atomic structure of the ectodomain from HIV-1 gp41
14. Evidence that a prominent cavity in the coiled coil of HIV type 1 gp41 is an attractive drug target
15. Inhibition of HIV type 1 infectivity by constrained α-helical peptides: Implication for the viral fusion mechanism
16. Empirical predictions of protein conformation
17. A thermodynamic scale for the helix-forming tendencies of the commonly occurring amino acids
18. Side chain contributions to the stability of alpha-helical structure in peptides
19. Structural basis of amino acid alpha helix propensity
20. Effect of central-residue replacements on the helical stability of a monomeric peptide
21. Helix capping
22. Helix stop signals in proteins and peptides: The capping box
23. The hydrophobic-staple motif and a role for loop-residures in alpha-helix stability and protein folding
24. Experimental analysis of the Schellman motif
25. Capping interactions in isolated alpha helices: Position-dependent substitution effects and structure of a serine-capped peptide helix
26. Development of an in vitro assay system for screening of gp41 inhibitory compounds
27. A cleavage method which minimizes side reactions following Fmoc solid peptide synthesis
28. Calculation of protein extinction co-efficients from amino acid sequence data
29. Inhibition of gp120-CD4 interaction by various plant extracts
30. Parameters of helix-coil transition theory for alanine-based peptides of varying chain lengths in water
31. Charge-relay at the peptide bond: A protein magnetic resonance study of solvation effects on the amide electron distribution
32. Effects of HPLC solvents and hydrophobic matrices on the secondary structure and quaternary structure of a model protein
33. Two interaction modes of the gp41-derived peptides with gp41 and their correlation with antimembrane fusion activity
34. Capture of an early fusion-active conformation of HIV-1 gp41
35. HIV entry and its inhibition